Search results
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill· 23 hours agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial...
What can Trump do about vaccines? More than you might think.
Politico via Yahoo News· 2 hours agoHis new anti-vaccine persona could have far-reaching consequences if he's elected to a second stint...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 16 hours agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 6 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 2 days agoThe shot, called Arexvy, is the first vaccine cleared by the FDA to protect that population from...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 days agovaccine is based on protein technology, differentiating it from Pfizer's and Moderna's messenger...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 6 days agoIn 2023, Moderna agreed to establish an mRNA manufacturing facility in Kenya. The new advanced facility will have the capacity to produce up to 500...
FDA panel recommends new COVID-19 vaccine formula for fall
UPI· 3 days agoDr. Peter Marks, who oversees the FDA's vaccine division, urged the committee to consider...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 6 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 4 days agoChatterjee and Wharton were speaking during a meeting of the FDA's Vaccines and Related Biological...
